Correlation Between Neximmune and Vor Biopharma
Can any of the company-specific risk be diversified away by investing in both Neximmune and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Vor Biopharma, you can compare the effects of market volatilities on Neximmune and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Vor Biopharma.
Diversification Opportunities for Neximmune and Vor Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neximmune and Vor is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Neximmune i.e., Neximmune and Vor Biopharma go up and down completely randomly.
Pair Corralation between Neximmune and Vor Biopharma
If you would invest 243.00 in Neximmune on November 5, 2024 and sell it today you would earn a total of 0.00 from holding Neximmune or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 5.26% |
| Values | Daily Returns |
Neximmune vs. Vor Biopharma
Performance |
| Timeline |
| Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Vor Biopharma |
Neximmune and Vor Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neximmune and Vor Biopharma
The main advantage of trading using opposite Neximmune and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.| Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
| Vor Biopharma vs. Monte Rosa Therapeutics | Vor Biopharma vs. Design Therapeutics | Vor Biopharma vs. Erasca Inc | Vor Biopharma vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |